|Bid||48.30 x 900|
|Ask||48.30 x 900|
|Day's Range||45.90 - 51.80|
|52 Week Range||41.13 - 171.09|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 02, 2022 - Feb 07, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||130.42|
The Dow Jones Industrial Average's worst daily plunge of the year sparked a split among market strategists on wether Friday was a good buying opportunity.
NEW ORLEANS, Nov. 26, 2021 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: Bristol-Myers Squibb Company (BMY)Class: Investors who received Contingent Value Rights (“CVRs”) (BMY.RT) in exchange for their shares of Celgene Corporation (CELG) pursuant to Bristol-Myers’ acquisition of Celgene on November 20, 2019Lead Plaintiff Motion
Work-from-home companies and Clorox rose. Cruise lines slumped.